IONTAS to Generate Antibodies using Mammalian Display Technology for a Global Biopharma
IONTAS’ platform allows for the construction of large libraries of monoclonal cell lines each displaying a different IgG-formatted antibody on the cell surface. Novel binders can be isolated from the libraries by using fluorescence-activated cell sorting on the basis of antigen binding. The system also has the potential to identify clones with development liabilities, such as self-aggregation, during the initial discovery phase.
IONTAS are a biotechnology company focused on antibody discovery and cutting-edge technology development. They are a leader in the discovery and optimisation of fully human antibodies.